CELLCURA Trademark

Trademark Overview


On Friday, July 25, 2025, a trademark application was filed for CELLCURA with the United States Patent and Trademark Office. The USPTO has given the CELLCURA trademark a serial number of 99302295. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 24, 2026. This trademark is owned by Cellcura Sciences, Inc.. The CELLCURA trademark is filed in the Pharmaceutical Products category with the following description:

Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations...
cellcura

General Information


Serial Number99302295
Word MarkCELLCURA
Filing DateFriday, July 25, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2026

Trademark Statements


Goods and ServicesMedical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 25, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellcura Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLehi, UT 84043
US

Party NameCellcura Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLehi, UT 84043
US

Trademark Events


Event DateEvent Description
Friday, July 25, 2025NEW APPLICATION ENTERED
Friday, July 25, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 11, 2025ASSIGNED TO EXAMINER
Friday, December 12, 2025NON-FINAL ACTION WRITTEN
Friday, December 12, 2025NON-FINAL ACTION E-MAILED
Friday, December 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 20, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 20, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 20, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 2, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 18, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 24, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 24, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED